508 related articles for article (PubMed ID: 10048582)
1. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
2. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development.
Nilsson EE; Doraiswamy V; Skinner MK
Mol Reprod Dev; 2003 Nov; 66(3):237-46. PubMed ID: 14502602
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce NC; Harris DL; Mello DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
[TBL] [Abstract][Full Text] [Related]
10. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
Rodeck U; Nishiyama T; Mauviel A
Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta2 inhibits growth of uveal melanocytes at physiological concentrations.
Hu DN; McCormick SA; Lin AY; Lin JY
Exp Eye Res; 1998 Aug; 67(2):143-50. PubMed ID: 9733581
[TBL] [Abstract][Full Text] [Related]
12. Differences in basic fibroblast growth factor RNA and protein levels in human primary melanocytes and metastatic melanoma cells.
Yamanishi DT; Graham MJ; Florkiewicz RZ; Buckmeier JA; Meyskens FL
Cancer Res; 1992 Sep; 52(18):5024-9. PubMed ID: 1516057
[TBL] [Abstract][Full Text] [Related]
13. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation.
Albino AP; Davis BM; Nanus DM
Cancer Res; 1991 Sep; 51(18):4815-20. PubMed ID: 1716514
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
15. Effects of TGF-beta s on the growth, collagen synthesis and collagen lattice contraction of human dental pulp fibroblasts in vitro.
Chan CP; Lan WH; Chang MC; Chen YJ; Lan WC; Chang HH; Jeng JH
Arch Oral Biol; 2005 May; 50(5):469-79. PubMed ID: 15777529
[TBL] [Abstract][Full Text] [Related]
16. FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytes.
von Willebrand M; Köhler K; Alanko T; Laiho M; Saksela O
Exp Dermatol; 2005 Mar; 14(3):202-8. PubMed ID: 15740593
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.
Bordoni R; Fine R; Murray D; Richmond A
J Cell Biochem; 1990 Dec; 44(4):207-19. PubMed ID: 2095366
[TBL] [Abstract][Full Text] [Related]
18. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
Picon A; Gold LI; Wang J; Cohen A; Friedman E
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
20. Differential cataractogenic potency of TGF-beta1, -beta2, and -beta3 and their expression in the postnatal rat eye.
Gordon-Thomson C; de Iongh RU; Hales AM; Chamberlain CG; McAvoy JW
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1399-409. PubMed ID: 9660488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
